Clinical Trials Browser

Urinary Bladder Neoplasms × infigratinib × Thoracic × Clear all

NCT01004224 2019-10-04

A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies

Phase 1 Completed

GenitourinaryThoracic

Urinary Bladder Neoplasms, Lung Neoplasms